FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082081271> ?p ?o ?g. }

• W2082081271 endingPage "2073" @default.
• W2082081271 startingPage "2061" @default.
• W2082081271 abstract "5H-Dibenzo[c,h]1,6-naphthyridine-6-ones can exhibit potent antitumor activity. The effect of varied substituents at the 5-position of 5H-8,9-dimethoxy-2,3-methylenedioxydibenzo[c,h]1,6-naphthyridine on relative cytotoxicity and topoisomerase I-targeting activity was evaluated. Potent TOP-1-targeting activity is observed when the 5-position is substituted with either a 2-(N,N-dimethylamino)ethyl group, as in 3a, or a 2-(pyrrolidin-1-yl)ethyl substituent, 3c. In contrast, the addition of a beta-methyl group or a beta-hydroxymethyl group to compound 3a, as in 3b and 3j, results in a loss of significant TOP1-targeting activity. While the presence of a 3-(N,N-dimethylamino)propyl substituent at the 5-position or a methyl(2-tetrahydrofuranyl) group allows for retention of TOP1-targeting activity, the 2-(4-methyl-1-piperazinyl)ethyl analogue, 3d, did not exhibit significant activity. Replacement of the N,N-dimethylamino group of 3a with either C(2)H(5) or OH, as in 3f and 3h, respectively, also had a negative impact on both cytotoxicity and TOP1-targeting activity. Treatment of 3a with LAH gave the 5,6-dihydrodibenzo[c,h]naphthyridine, 4a. This dihydro derivative has approximately 2/3 the potency of 3a as a TOP1-targeting agent. Compounds 3a, 3b, 3h, 3i, and 4a were evaluated for antitumor activity in the human tumor xenograft model using athymic nude mice. The non-estrogen responsive breast tumor cell line, MDA-MB-435, was used in these assays. Compound 3a proved to be effective in regressing tumor growth in vivo when administered either by ip injection or orally 3x week at a dose of 2.0mg/kg. Compound 4a when administered orally 5x weekly at a dose of 40 mg/kg also suppressed tumor growth." @default.
• W2082081271 created "2016-06-24" @default.
• W2082081271 creator A5007218289 @default.
• W2082081271 creator A5019938572 @default.
• W2082081271 creator A5029554853 @default.
• W2082081271 creator A5032798692 @default.
• W2082081271 creator A5057145998 @default.
• W2082081271 creator A5061198316 @default.
• W2082081271 creator A5069618928 @default.
• W2082081271 creator A5078674610 @default.
• W2082081271 creator A5080143961 @default.
• W2082081271 date "2003-05-01" @default.
• W2082081271 modified "2023-10-10" @default.
• W2082081271 title "5H-Dibenzo[c,h]1,6-naphthyridin-6-ones: novel topoisomerase I-Targeting anticancer agents with potent cytotoxic activity" @default.
• W2082081271 cites W1524137609 @default.
• W2082081271 cites W1629179716 @default.
• W2082081271 cites W1966831567 @default.
• W2082081271 cites W1985349868 @default.
• W2082081271 cites W1985426723 @default.
• W2082081271 cites W1990991016 @default.
• W2082081271 cites W1994240050 @default.
• W2082081271 cites W2008902935 @default.
• W2082081271 cites W2016254453 @default.
• W2082081271 cites W2018557806 @default.
• W2082081271 cites W2019672150 @default.
• W2082081271 cites W2032956537 @default.
• W2082081271 cites W2035074423 @default.
• W2082081271 cites W2045116568 @default.
• W2082081271 cites W2071159861 @default.
• W2082081271 cites W2075357854 @default.
• W2082081271 cites W2077973224 @default.
• W2082081271 cites W2082596157 @default.
• W2082081271 cites W2089374817 @default.
• W2082081271 cites W2096712606 @default.
• W2082081271 cites W2102345056 @default.
• W2082081271 cites W2103489107 @default.
• W2082081271 cites W2110974225 @default.
• W2082081271 cites W2113007993 @default.
• W2082081271 cites W2114918609 @default.
• W2082081271 cites W2123566067 @default.
• W2082081271 cites W2133713837 @default.
• W2082081271 cites W261007534 @default.
• W2082081271 cites W2951190103 @default.
• W2082081271 cites W4233567369 @default.
• W2082081271 doi "https://doi.org/10.1016/s0968-0896(03)00051-8" @default.
• W2082081271 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12670657" @default.
• W2082081271 hasPublicationYear "2003" @default.
• W2082081271 type Work @default.
• W2082081271 sameAs 2082081271 @default.
• W2082081271 citedByCount "100" @default.
• W2082081271 countsByYear W20820812712012 @default.
• W2082081271 countsByYear W20820812712013 @default.
• W2082081271 countsByYear W20820812712014 @default.
• W2082081271 countsByYear W20820812712015 @default.
• W2082081271 countsByYear W20820812712016 @default.
• W2082081271 countsByYear W20820812712017 @default.
• W2082081271 countsByYear W20820812712018 @default.
• W2082081271 countsByYear W20820812712019 @default.
• W2082081271 countsByYear W20820812712020 @default.
• W2082081271 countsByYear W20820812712021 @default.
• W2082081271 countsByYear W20820812712022 @default.
• W2082081271 countsByYear W20820812712023 @default.
• W2082081271 crossrefType "journal-article" @default.
• W2082081271 hasAuthorship W2082081271A5007218289 @default.
• W2082081271 hasAuthorship W2082081271A5019938572 @default.
• W2082081271 hasAuthorship W2082081271A5029554853 @default.
• W2082081271 hasAuthorship W2082081271A5032798692 @default.
• W2082081271 hasAuthorship W2082081271A5057145998 @default.
• W2082081271 hasAuthorship W2082081271A5061198316 @default.
• W2082081271 hasAuthorship W2082081271A5069618928 @default.
• W2082081271 hasAuthorship W2082081271A5078674610 @default.
• W2082081271 hasAuthorship W2082081271A5080143961 @default.
• W2082081271 hasConcept C109316439 @default.
• W2082081271 hasConcept C147897179 @default.
• W2082081271 hasConcept C154317977 @default.
• W2082081271 hasConcept C178790620 @default.
• W2082081271 hasConcept C185592680 @default.
• W2082081271 hasConcept C193042331 @default.
• W2082081271 hasConcept C202751555 @default.
• W2082081271 hasConcept C2778565081 @default.
• W2082081271 hasConcept C2778689049 @default.
• W2082081271 hasConcept C2780263894 @default.
• W2082081271 hasConcept C2780299520 @default.
• W2082081271 hasConcept C2780591741 @default.
• W2082081271 hasConcept C2781311116 @default.
• W2082081271 hasConcept C46062151 @default.
• W2082081271 hasConcept C55493867 @default.
• W2082081271 hasConcept C57992300 @default.
• W2082081271 hasConcept C71240020 @default.
• W2082081271 hasConceptScore W2082081271C109316439 @default.
• W2082081271 hasConceptScore W2082081271C147897179 @default.
• W2082081271 hasConceptScore W2082081271C154317977 @default.
• W2082081271 hasConceptScore W2082081271C178790620 @default.
• W2082081271 hasConceptScore W2082081271C185592680 @default.
• W2082081271 hasConceptScore W2082081271C193042331 @default.
• W2082081271 hasConceptScore W2082081271C202751555 @default.
• W2082081271 hasConceptScore W2082081271C2778565081 @default.
• W2082081271 hasConceptScore W2082081271C2778689049 @default.

• next